"Nourish to Flourish": complementary feeding for a healthy infant gut microbiome-a non-randomised pilot feasibility study

• Published in: Pilot and feasibility studies 2022-05, Vol.8 (1), p.103-103, Article 103
• Main Authors: Lovell, Amy L, Eriksen, Hannah, McKeen, Starin, Mullaney, Jane, Young, Wayne, Fraser, Karl, Altermann, Eric, Gasser, Olivier, Kussmann, Martin, Roy, Nicole C, McNabb, Warren C, Wall, Clare R
• Format: Article
• Language: English
• Subjects: Analysis; Babies; Clinical trials; Complementary feeding; Data collection; Data entry; Digestive system; Feasibility; Feasibility studies; Food; Food and nutrition; Gestational age; Illnesses; Immune health; Infant; Infants; Infections; Metabolism; Metabolites; Microbiome; Microbiota; Milk; Parents & parenting; Physiological aspects; Prebiotics; Probiotics; Respiratory tract diseases; Retention; Urine; Weaning
• ISSN: 2055-5784; 2055-5784
• DOI: 10.1186/s40814-022-01059-3

The introduction of complementary foods and changes in milk feeding result in modifications to gastrointestinal function. The interplay between indigestible carbohydrates, host physiology, and microbiome, and immune system development are areas of intense research relevant to early and later-life health. This 6-month prospective non-randomised feasibility study was conducted in Auckland, New Zealand (NZ), in January 2018. Forty parents/caregivers and their infants were enrolled, with 30 infants allocated to receive a prebiotic NZ kūmara (flesh and skin; a type of sweet potato) prepared as a freeze-dried powder, and ten infants allocated to receive a commercially available probiotic control known to show relevant immune benefits (10 CFU Bifidobacterium lactis BB-12®). The primary outcome was the study feasibility measures which are reported here. Recruitment, participant retention, and data collection met feasibility targets. Some limitations to biological sample collection were encountered, with difficulties in obtaining sufficient plasma sample volumes for the proposed immune parameter analyses. Acceptability of the kūmara powder was met with no reported adverse events. This study indicates that recruiting infants before introducing complementary foods is feasible, with acceptable adherence to the food-based intervention. These results will inform the protocol of a full-scale randomised controlled trial (RCT) with adjustments to the collection of biological samples to examine the effect of a prebiotic food on the prevalence of respiratory tract infections during infancy. Trial registration Australia New Zealand Clinical Trials Registry ACTRN12618000157279 . Prospectively registered on 02/01/2018.